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Abstract
Gram-negative bacteria produce outer membrane vesicles that play a role in the delivery of virulence factors to host cells.
However, little is known about the membrane-derived vesicles (MVs) produced by Gram-positive bacteria. The present
study examined the production of MVs from Staphylococcus aureus and investigated the delivery of MVs to host cells and
subsequent cytotoxicity. Four S. aureus strains tested, two type strains and two clinical isolates, produced spherical
nanovesicles during in vitro culture. MVs were also produced during in vivo infection of a clinical S. aureus isolate in a mouse
pneumonia model. Proteomic analysis showed that 143 different proteins were identified in the S. aureus-derived MVs. S.
aureus MVs were interacted with the plasma membrane of host cells via a cholesterol-rich membrane microdomain and
then delivered their component protein A to host cells within 30 min. Intact S. aureus MVs induced apoptosis of HEp-2 cells
in a dose-dependent manner, whereas lysed MVs neither delivered their component into the cytosol of host cells nor
induced cytotoxicity. In conclusion, this study is the first report that S. aureus MVs are an important vehicle for delivery of
bacterial effector molecules to host cells.
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Introduction
Staphylococcus aureus causes a wide range of diseases in humans,
from uncomplicated local infection to life threatening systemic
infection, both in health care facilities and the community [1].
Most staphylococcal infections can be successfully treated with
antibiotics, but strains resistant to vancomycin have emerged,
which is of great concern in clinical setting [2–4]. The ability of S.
aureus to cause a wide range of diseases is associated with various
structural components such as the capsule, peptidoglycan, teichoic
acid, and protein A, toxins such as cytotoxins, exfoliative toxins,
enterotoxins, and toxic shock syndrome toxin-1 (TSST-1), and
enzymes such as coagulase, catalase, hyaluronidase, fibrinolysin,
lipase, and nuclease [1,5–7]. However, the secretion of these
virulence determinants from S. aureus and their delivery to host
cells has not been fully characterized. Lee et al. [8] recently
demonstrated that S. aureus produced membrane-derived vesicles
(MVs) during in vitro culture and many virulence-associated
proteins were identified in the S. aureus MVs. Therefore, it is
possible that S. aureus MVs play a role in the delivery of virulence
factors to host cells, which is similar to that of the outer membrane
vesicles (OMVs) of Gram-negative bacteria [9].
A variety of Gram-negative pathogenic or environmental
bacteria secretes OMVs, which are produced during normal
bacterial growth [10]. OMVs are spherical and bilayered
nanovesicles with an average diameter of 20–300 nm. They are
composed of lipopolysaccharides, phospholipids, outer membrane
proteins, periplasmic proteins, cytosolic proteins, and even nucleic
acids [9,11–13]. In addition, virulence factors, like cytolysin A in
Escherichia coli [14], heat-labile toxin in enterotoxigenic E. coli [15],
hemolytic phospholipase C and alkaline phosphatase in Pseudomo-
nas aeruginosa [16], and leukotoxin in Actinobacillus actinomycetemco-
mitans [17], have been identified, and their contributions to
bacterial pathogenesis have been characterized. In contrast, little is
known about such processes in Gram-positive bacteria. MV
production has been reported in S. aureus, Bacillus anthracis, B. cereus,
and B. subtilis [8,18–19], and more recently S. aureus MVs have
been shown to induce atopic dermatitis-like inflammation [20].
However, the production of MVs from Gram-positive bacteria
during in vivo infection and their direct associations with host cell
pathology have not been determined.
The present study examined the production of MVs from a
clinical S. aureus isolate during in vivo infection and further
investigated the delivery of bacterial effector molecules to host cells
via MVs and subsequent cytotoxicity. We report that S. aureus
produces MVs during in vivo infection and also that S. aureus MVs
play a role inthe deliveryof bacterialeffector molecules to host cells.
Results
Production of MVs from S. aureus
Lee et al. [8] were the first to demonstrate that S. aureus ATCC
14458 produced MVs during in vitro culture. However, MV
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27958production was not reported in other S. aureus strains. To
determine whether MV production is common feature of S.
aureus, two type strains, ATCC 25923 (control strain for
antimicrobial susceptibility test) and ATCC 700699 (vancomy-
cin-intermediate S. aureus Mu50), and two clinical isolates, TSST-1
producing S. aureus 103D and methicillin-resistant S. aureus
(MRSA) 06ST1048, were cultured in Luria-Bertani (LB) broth
and the extracellular vesicles were collected from the culture
supernatants. Transmission electron microscopy (TEM) analysis
showed that all S. aureus strains tested produced MVs during in vitro
culture. S. aureus-derived vesicles were spherical and bilayered
structures with the diameters of approximately 20 to 130 nm
(Fig. 1A-1D). Next, in order to determine whether S. aureus
produced MVs during in vivo infection, mice were infected
intratracheally with S. aureus 06ST1048 and sacrificed 18 h after
bacterial administration. Histological examination showed edema,
hemorrhage, and infiltration of polymorphonuclear cells in the
tissues of both lungs (data not shown), suggesting the occurrence of
pneumonia. TEM analysis of the infected lung tissues revealed the
budding of spherical nanovesicles from bacterial surfaces (Fig. 1E).
Moreover, the secreted MVs were observed in the surrounding
milieu (Fig. 1F). These results indicate that S. aureus produces and
secretes MVs into extracellular milieu during both in vitro culture
and in vivo infection.
Identification of proteins in S. aureus MVs
To analyze proteins packaged in the S. aureus MVs, the purified
MVs from S. aureus 06ST1048 were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Many
protein bands were identified in the MV fraction, but the positions
of major bands were different in the culture supernatant and the
MV fraction (Fig. 2A). To identify proteins packaged in the S.
aureus-derived MVs, proteomic analysis was performed. A total of
143 proteins were identified in the MVs derived from S. aureus
06ST1048 (Table S1). A putative pyruvate dehydrogenase E1
component, beta subunit (D1GS80) with the expected molecular
mass of 35.2 kDa was detected in the highest abundance, followed
by dihydrolipoamide acetyltransferase component of pyruvate
dehydrogenase complex (D1GS81) with the expected molecular
mass of 46.4 kDa. The identified proteins were classified into five
groups based on the location of proteins in the bacteria: cytoplasm
(n=96), cytoplasmic membrane (n=28), cell wall (n=3), extra-
cellular region (n=12), and unknown localization (n=4). Based on
the proteome results from S. aureus-derived MVs, Western blot
analysis was performed to detect b-lactamases in the MVs. b-
lactamases were identified in MVs from S. aureus 06ST1048 isolate
(Fig 2B). To determine whether the b-lactamases packaged in the
MVs were biologically active enzymes, the purified MVs were
incubated with the chromogenic cephalosporin nitrocefin, and
hydrolysis of the b-lactamase substrate was monitored [21]. This
revealed b-lactamases in the MVs degraded nitrocefin and resulted
in a brown colorization of nitrocefin, thereby suggesting that
biologically active b-lactamases were secreted from bacteria via the
MVs. To identify cell wall-associated proteins in the MVs,
Western blot analysis of immunoglobulin G-binding protein
(protein A), a specific membrane protein of S. aureus, was
performed. S. aureus MVs contained protein A with a molecular
size of 42 kDa (Fig 2B). These results suggest that many bacterial
proteins, including biologically active proteins, are packaged in the
S. aureus MVs.
Delivery of MV components to host cells
To determine the delivery of bacterial components to host cells
via the MVs, the time obligation for the entry of protein A, a
documented MV protein, in HEp-2 cells was examined by
Western blot. Protein A was first detected in the cells within
30 min, and then intact and degraded forms were observed at
24 h after treatment of the MVs (Fig. 3A). To determine whether
MVs played a role in the delivery of bacterial effector molecules to
host cells, HEp-2 cells were treated with intact MVs and MVs
Figure 1. Production of MVs from S. aureus. (A to D) Transmission electron micrograph of MVs prepared from S. aureus ATCC 25923 (A), ATCC
700699 (B), 103D (C), and 06ST1048 (D) cultured in LB broth. (E and F) Production and secretion of MVs from S. aureus 06ST1048 during in vivo
infection. Neutropenic mice were infected with 1610
7 CFU of bacteria intratracheally. The S. aureus-infected mice were sacrificed 18 h after bacterial
injection. Arrows indicate the spherical nanovesicles from S. aureus.
doi:10.1371/journal.pone.0027958.g001
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were permeabilized with Triton X-100 and treated with anti-
protein A antibody, followed by Alexa Fluor 488 for protein A.
Green fluorescence was noted principally in the cytosolic
compartment of the cells treated with intact MVs, whereas the
fluorescent intensity of protein A was not observed in the cells
treated with lysed MVs (Fig. 3B). These suggest that MVs are a
vehicle for the delivery of bacterial components to host cells. In the
next series of experiments, we determined the delivery mechanism
of MV components to host cells. Since OMVs from Gram-
negative bacteria were interacted with the plasma membrane of
host cells via lipid rafts [10,22], HEp-2 cells were pretreated with a
cholesterol-destroying agent, methyl-b-cyclodextrin (MbCD), and
then treated with S. aureus MVs for 24 h. This revealed that
MbCD abolished the entry of the MV component, protein A, in
host cells (Fig. 3B), thereby indicating that MV components enter
the cytosol of host cells via a cholesterol-rich membrane
microdomain.
Host cell death induced by S. aureus MVs
In order to determine whether MVs from S. aureus 06ST1048
induced host cell pathology, HEp-2 cells were treated with various
concentrations of MVs for 24 h. The morphology of HEp-2 cells
treated with 50 mg/ml of MVs showed cellular shrinkage, nuclear
condensation, and nuclear fragmentation (Fig. 4A), suggesting that
S. aureus MVs induce host cell death. To analyze the cell death
mechanism induced by the S. aureus MVs, HEp-2 cells were treated
with various concentrations of MVs for 24 h and then stained with
Annexin V and propidium iodide (PI). Flow cytometric analysis
showed that S. aureus MVs induced apoptotic cell death (Annexin
V
+/PI
2 and Annexin V
+/PI
+ fractions) (Fig. 4B). The cytotoxic
effect on HEp-2 cells was statistically significant at a concentration
of $20 mg/ml of MVs (p,0.05) and was apparently dose-
dependent (Fig. 4C). To determine whether lysed MVs induced
cytotoxicity, HEp-2 cells were treated with various concentrations
of lysed MVs for 24 h. Unlike intact MVs, lysed MVs did not
induce cytotoxicity (Fig. 4C). Pretreating HEp-2 cells with MbCD
and then treating them with 50 mg/ml of MVs for 24 h did not
induce cytotoxicity (9.262.6%), although the same concentration
of MVs did induce cytotoxicity (24.161.7%). These results suggest
that the delivery of MV components to cytosol of host cells is
prerequisite for cytotoxicity.
Discussion
Membrane-derived vesicle formation and the delivery of
virulence determinants to host cells via these vesicular structures
appear to be a conserved process among pathogenic Gram-
negative bacteria and eukaryotic pathogens [9,10,23]. However,
the production of MVs from Gram-positive bacteria during
infection and their contribution to bacterial pathogenesis have not
been determined. In the current study, we demonstrate for the first
time that Gram-positive bacterium, S. aureus, produces and secretes
MVs into extracellular milieu during in vivo infection. S. aureus MVs
serve as a transport system for virulence-associated components, as
demonstrated by host cell death induced by intact MVs, but not by
lysed MVs. Thus, our results extend the role of extracellular
vesicles in bacterial pathogenesis to Gram-positive bacteria.
The production of MVs was previously identified in S. aureus
ATCC 14458 [8], but not in other S. aureus strains. In the present
study, we demonstrate that MV production is a common feature of
S. aureus. Despite the structural differences between Gram-positive
and Gram-negative bacteria, the morphological characteristics of
MVs from Gram-positive bacteria shared many common features
with OMVs of Gram-negative bacteria [8]. OMVs were spherical
and bilayered structures with an average diameter of 20–300 nm
[24–27]. Similarly, MVs shed from S. aureus and B. anthracis were
bilayered spherical vesicles [8,18], but the size of MVs from Gram-
positive bacteria was relatively smaller than that of OMVs from
Gram-negative bacteria. Several studies have demonstrated that a
membranous structure of extracellular vesicles from both Gram-
positive and Gram-negative bacteria provides protection for
effector molecules like toxins, enzymes, and DNA from the
extracellular harsh environment and delivers them to target
molecules or cells efficiently [18,28–32]. In this study, the
biologically active b-lactamases were detected in the MVs of a
clinical S. aureus isolate as well as MVs of S. aureus ATCC 14458
[8], thus allowing the concentrated delivery of b-lactamases to
target antimicrobial agents via the MVs. In addition, intact MVs
efficiently delivered the MV component, protein A, to host cells,
whereas the protein A from lysed MVs did not enter the cytosol of
host cells. These results suggest that S. aureus MVs are an
important vehicle for the delivery of bacterial effector molecules to
host cells, a function which may contribute to pathogenesis of S.
aureus during infection.
Figure 2. Proteins identified in the S. aureus-derived MVs. SDS-
PAGE of proteins packaged in the MVs from S. aureus 06ST1048 (A) and
its Western blot analysis (B). The samples were separated on 12% SDS-
PAGE and immunoblotted with anti-protein A and anti-b-lactamases
antibodies. Lanes M, molecular weight maker; CL, bacterial cell lysate
fraction; S, supernatant fraction; and MVs, membrane-derived vesicle
fraction.
doi:10.1371/journal.pone.0027958.g002
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confirmed in a variety of pathogenic Gram-negative bacteria [33–
37], but the role of MVs in the pathogenesis of Gram-positive
bacteria was not fully determined. Rivera et al. [18] recently
reported that B. anthracis secreted toxin components, protective
antigen, lethal factor, and edema factor, and anthrolysin via the
MVs [18]. Lee et al. [8] also demonstrated that S. aureus MVs
contained extracellular and membrane-associated virulence fac-
tors, including toxins, adhesins, proteolysin, coagulase, and other
tissue destruction enzymes. Virulence-associated proteins, such as
toxins lethal to host cells, extracellular proteases, bacterial
adherence and invasion factors in host cells, and immune evasion
proteins, accounted for 11% of the 90 protein components
identified in the MVs from S. aureus ATCC 14458, whereas
proteins associated with information storage and processing and
with metabolism accounted for 55% [8]. Moreover, another
report from the same group showed that S. aureus MVs produced
proinflammatory mediators, such as interleukin-6, thymic stromal
lymphopoietin, macrophage inflammatory protein-1a, and eo-
taxin, and induced atopic dermatitis-like skin inflammation [20].
Figure 3. Delivery of protein A packaged in the S. aureus MVs to host cells. (A) Delivery of protein A to host cells via the MVs. HEp-2 cells
were treated with S. aureus MVs (20 mg/ml of protein concentrations) for the indicated times. Cell lysates were separated on 12% SDS-PAGE,
transferred to membranes, and immunoblotted with anti-protein A and b-actin antibodies. Both full-length and degraded forms of protein A were
appeared. (B) HEp-2 cells were treated with intact or lysed MVs (20 mg/ml of protein concentrations) for 24 h. HEp-2 cells were pretreated with 10 mM
MbCD for 45 min at 37uC. The cells were fixed, permeabilized, and stained with a rabbit anti-protein A antibody, followed by Alexa FluorH 488-
conjugated rabbit IgG (green). DAPI was used to stain the nuclei (blue). The analytical sectioning was performed from the top to the bottom of the
cells. The figure represents all projection of sections in one picture.
doi:10.1371/journal.pone.0027958.g003
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aureus-derived MVs. The cytoplasmic proteins were the most
abundant (67.1%), followed by membrane proteins (19.6%).
Pathogenesis-associated proteins, including IgG-binding protein,
ferritin, putative ferrichrome-binding lipoprotein precursor, ABC
transporter extracellular binding protein, and lipoprotein for high-
affinity iron ion transport, and proteins associated with antibiotic
resistance, including b-lactamase, penicillin-binding protein 2, and
membrane protein oxaA, were found in the S. aureus MVs. These
results suggest that bacterial effectors packaged in the MVs are
directly associated with bacterial pathogenesis.
Nothing has been reported regarding the interaction of S. aureus
MVs with host cells and subsequent cellular pathology. The
OMVs from Gram-negative bacteria could interact with host cells
via either a receptor-mediated endocytic pathway or fusion with
the host cell plasma membrane [10,38]. Bomberger et al. [16]
showed that OMVs secreted by Pseudomonas aeruginosa delivered
multiple virulence factors directly into the cytoplasm of host cells
by fusion of OMV with lipid rafts in the plasma membrane. They
therefore proposed that secreted virulence factors were not
released individually, but that bacterial derived OMVs delivered
these factors simultaneously [16]. Our previous study on
Acinetobacter baumannii OMVs also showed that a cholesterol-rich
membrane microdomain was required for the delivery of outer
membrane protein A packaged in A. baumannii OMVs to the
cytosol of host cells [22]. Interestingly, the present study found a
similar mechanism, in which S. aureus MVs delivered MV
components to host cells through the interactions with lipid raft
machinery, suggesting a common entry mechanism for the MVs
derived from Gram-negative and Gram-positive bacteria. Intact
MVs derived from S. aureus 06ST1048 isolate induced host cell
death in a dose-dependent manner, whereas lysis of MVs or
Figure 4. Host cell death induced by the S. aureus MVs. (A) HEp-2 cells were treated with 50 mg/ml of MVs for 24 h and stained with DAPI.
Upper and lower panels are untreated control cells and S. aureus MV-treated cells, respectively. S. aureus MVs induced host cell pathology, such as
condensation of nuclei, nuclear fragmentation and cellular shrinkage. DIC, differential interference contrast microscopy. (B) Flow cytometric analysis
of cell death induced by the S. aureus MVs. Upper panel, control cells without MVs and with PBS for 24 h. Lower panel, HEp-2 cells were treated with
various concentrations of S. aureus MVs for 24 h. Representative data from three independent experiments are shown. In the graph, cells in right
upper and lower parts represent apoptotic cells, and cells in left upper part represent necrotic cells. (C) HEp-2 cells were treated with various
concentrations of intact MVs or MVs lysed with EDTA for 24 h. Cells were stained with Annexin V and PI, and then 10
4 cells were analyzed by flow
cytometry. All dead cell population, including Annexin V
+/PI
+, Annexin V
+/PI
2 and Annexin V
2/PI
+ fractions, were calculated. Data are presented as
mean 6 standard error in three independent experiments. *Statistically significant at p,0.05 using a Student’s t-test.
doi:10.1371/journal.pone.0027958.g004
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the delivery of MV components nor induced cytotoxicity. This
finding suggests that the entry of MV components into the cytosol
of host cells is prerequisite for cytotoxicity. Although we identified
proteins packaged in the S. aureus MVs, specific cytotoxic
molecules were not characterized in this study. Further studies
into the identification of specific virulence factors that are
responsible for host cell damage packaged in the MVs and
immune response against MVs are expected to provide insights
into the association of S. aureus pathogenesis and disease
progression.
In conclusion, our study demonstrates that S. aureus MVs, like
OMVs from Gram-negative bacteria, provide an important
vehicle for the delivery of bacterial effector molecules to host
cells. To the best of our knowledge, this work represents the first
study to demonstrate the entry mechanism and cytotoxicity of S.
aureus MVs in host cells. Our findings have significant implications
for the study of Gram-positive bacterial pathogenesis and the
development of a new therapeutic target against S. aureus.
Materials and Methods
Bacterial strain and cell culture
Four S. aureus strains, two type strains (ATCC 25923 and ATCC
700699) and two clinical isolates (TSST-1 producing S. aureus
103D and MRSA 06ST1048), were used in this study. S. aureus
06ST1048 that was isolated from the blood of a hospitalized
patient at the Kyungpook National University Hospital in Daegu,
Korea and S. aureus 103D that was isolated from the skin of atopic
dermatitis at the same hospital were obtained from National
Culture Collection for Pathogens-Kyungpook National University
Hospital (Daegu, Korea). S. aureus 06ST1048 is resistant to
oxacillin (minimum inhibitory concentration of oxacillin, .
512 mg/ml) and S. aureus 103D carries TSST-1 gene. S. aureus
was identified using both the Vitek Auto Microbic System
(BioMe ´rieux Vitek Systems Inc.) and API kit (bioMerieux, Marcy
l’Etoile, France). The organisms were maintained on blood agar
plates and cultured in LB broth. HEp-2 cells derived from human
laryngeal carcinoma were obtained from Korean Cell Line Bank
(Seoul, Korea) and were grown in Dulbecco’s modified Eagle’s
medium (HyClone) supplemented with 10% fetal bovine serum
(HyClone), 2 mM L-glutamine, 1,000 U/ml penicillin G, and
50 mg/ml streptomycin at 37uCi n5 %C O 2.
Purification of MVs from culture supernatants
The extracellular vesicles of S. aureus were prepared from
bacterial culture supernatants using a method adapted from Wai
et al. [14]. S. aureus 06ST1048 was inoculated into 500 ml of LB
broth and grown until the optical density at 600 nm (OD600)
reached 1.0 at 37uC with shaking. After bacterial cells were
removed by centrifugation at 6000 g for 15 min, the supernatants
were filtered through a 0.2 mm hollow fiber membrane (GE
Healthcare) to remove residual bacteria and cellular debris, and
they were then concentrated by ultrafiltration with a QuixStand
Benchtop System (GE Healthcare) using a 100 kDa hollow fiber
membrane (GE Healthcare). The MV fractions were centrifuged
at 150,000 g for 3 h at 4uC, and the pellets containing MVs were
resuspended in phosphate-buffered saline (PBS). The samples were
layered over a sucrose gradient (1.25 ml each of 2.5, 1.6, and
0.6 M sucrose) and centrifuged at 200,000 g for 20 h at 4uC; four
fractions of equal volumes were collected from the bottom.
Sucrose was removed by ultracentrifugation at 150,000 g for 3 h at
4uC, and the purified MVs were resuspended in PBS. The sucrose
density and protein concentration were determined using
refractometry and the Bradford assay (BioRad Laboratories),
respectively. The protein concentration was determined using the
modified BCA assay (Thermo Scientific). The purified MVs were
checked for sterility and stored at 280uC until used.
SDS-PAGE and Western blot analysis
The purified MVs were resuspended in SDS-PAGE sample
buffer (1M Tris HCl pH 6.8, 10% SDS, 1% bromophenol blue,
glycerol, and b-mercaptoethanol) and boiled for 10 min. A sample
corresponding to 10 mg of protein concentration was separated by
12% SDS-PAGE, and the gels were stained with Coomassie
Brilliant Blue R-250 (Bio-Rad). The proteins on the gels were
transferred to a nitrocellulose membrane (Amersham Pharmacia
Biotech) and then analyzed by Western blotting using rabbit anti-
protein A antibodies (Sigma life Science) and mouse anti-b-
lactamase immune sera, which were produced in our laboratory.
The membrane was incubated with a secondary antibody coupled
to horseradish peroxidase and developed by an enhanced
chemiluminescence system (ECL plus; Amersham Pharmacia
Biotech).
Identification of proteins in S. aureus MVs
One-dimensional electrophoresis-liquid chromatography-tan-
dem mass spectrometry (1-DE-LC-MS/MS) was performed to
identify proteins packaged in the S. aureus MVs. Proteins were
separated via 12% SDS-PAGE and in-gel digested. The protein
digests were resolved in 15 ml of 0.02% formic acid in 0.5% acetic
acid, and the samples were concentrated on a MGU30-C18
trapping column (LC Packings) and a nano-column (C18 reverse-
phase column, Proxeon). The peptides were eluted by 0–65%
acetonitrile for 80 min. All MS and MS/MS spectra in the LCQ-
Deca ESI ion trap mass spectrometer were acquired in data-
dependent mode. The MS/MS spectra were searched using
MASCOT software (Matrix Science, Inc.) using the genome data
of S. aureus TW20 from NCBInr (http://www.ncbi.nlm.nih.gov/)
and the decoy sequence database. The exponentially modified
protein abundance index (emPAI) was generated using MASCOT
software [39].
TEM analysis
The purified MV samples were applied to copper grids
(Electron microscopy sciences, Hatfield, PA) and stained with
2% uranyl acetate. The lung tissues were fixed with 2.5%
glutaraldehyde and post-fixed in 1% osmium tetroxide. The
samples were dehydrated in a series of ethanol concentrations and
embedded in Epon. Thin sections were cut with an ultramicro-
tome (RMC Boeckeler Instruments) equipped with a diamond
knife and stained with 3% uranyl acetate and lead citrate. The
samples were then visualized with a TEM (Hitachi H-7500,
Hitachi, Japan) operated at 120 kV.
Confocal microscopy
The cultured HEp-2 cells were seeded at a density of 5610
4 on
glass coverslips. After treating the MVs, cells were washed with
PBS, fixed in 4% paraformaldehyde, and permeabilized for
10 min in PBS containing 0.25% Triton X-100. The MVs were
labeled with an anti-rabbit protein A antibody, followed by Alexa-
488-conjugated goat anti-rabbit antibody (Molecular Probes). The
nuclei of the cells were stained with 49, 6-diamidino-2-phenyllin-
dole dihydrochloride (DAPI) (Molecular Probes). HEp-2 cells were
treated with 10 mM MbCD (Sigma-Aldrich) to disrupt cholester-
ol-rich membrane domains for 45 min at 37uCi naC O 2
incubator. After washing with PBS, cells were treated with MVs.
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microscope.
Flow cytometric analysis
The cells were treated with various concentrations of MVs for
24 h and then stained with fluorescein isothiocyanate (FITC)-
conjugated Annexin V and PI (BD Pharmingen) according to the
manufacturer’s instructions. The cells were stained with FITC-
conjugated Annexin V in Annexin V binding buffer for 15 min. PI
was added to determine alterations in cell membrane integrity. To
determine the cytotoxic effect of lysed MVs, the purified MVs
were lysed with 0.1M EDTA at 37uC for 1 h and then treated to
HEp-2 cells for 24 h. The samples were immediately analyzed by
the flow cytometry and CellQuest Pro software (BD Biosciences).
For each sample, 10
4 cells were acquired for data analysis.
Mouse pneumonia model
Eight-week-old female C57BL/6 mice were used in this study.
Immunocompromised mice were infected with S. aureus
06ST1048. Neutropenic mice were induced via intraperitoneal
injections of cyclophosphamide (150 mg/kg) on days -4 and -3
before bacterial injection [22,40]. The mice with neutropenia were
anesthetized with pentobarbital and then 100 mlo f1 610
8 cfu/ml
of bacteria were administered intratracheally. The control mice
were injected with 100 ml of PBS (pH 7.4). The mice were
sacrificed 18 h after bacterial challenge, and the lungs were
removed. All procedures involving animals were approved by the
Animal Care Committee of Kyungpook National University
(KNU2010-40).
Statistical analysis
The statistical significance of the data was determined by
Student’s t-test. A p value of ,0.05 was considered to be
statistically significant.
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Table S1 Proteins identified in the membrane vesicles derived
from S. aureus 06ST1048 using 1-DE and LC-MS/MS analysis
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